BridgeMD
Compares treatment options for Kidney Stones
Official title Modified Mini-PCNL Versus Standard PCNL for Complex Kidney Stones
ClinicalTrials.gov ID: NCT07697677
What this study is testing
- What it's testing
- Kidney stones that are large or complex are often treated with percutaneous nephrolithotomy, also called PCNL. Standard PCNL uses a larger access tract and is effective for removing complex kidney stones, but it may be associated with more bleeding, pain, and recovery burden.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Adults aged ≥18 years.
- Serum creatinine ≤133 μmol/L.
- American Society of Anesthesiologists (ASA) physical status classification I-III.
- S.T.O.N.E. score ≥8.
- Complex renal stones confirmed by noncontrast computed tomography, including stone surface area \>1500 mm², multiple calyceal stones, partial or...
You likely can't join if
- Solitary kidney.
- Morbid obesity (body mass index ≥35 kg/m²).
- Previous renal transplantation or urinary diversion.
- Congenital abnormalities of the urinary tract.
- Pregnancy.
- Uncorrected coagulopathy.
See the full eligibility criteria
- Adults aged ≥18 years.
- Serum creatinine ≤133 μmol/L.
- American Society of Anesthesiologists (ASA) physical status classification I-III.
- S.T.O.N.E. score ≥8.
- Complex renal stones confirmed by noncontrast computed tomography, including stone surface area \>1500 mm², multiple calyceal stones, partial or complete staghorn calculi, or complex anatomical conditions.
- Patients who provide written informed consent and agree to undergo either modified mini-percutaneous nephrolithotomy or standard percutaneous nephrolithotomy.
- Solitary kidney.
- Morbid obesity (body mass index ≥35 kg/m²).
- Previous renal transplantation or urinary diversion.
- Congenital abnormalities of the urinary tract.
- Pregnancy.
- Uncorrected coagulopathy.
- Active urinary tract infection.
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.